PUMA BIOTECHNOLOGY, INC. (PBYI) › Shareholders' EquityPUMA BIOTECHNOLOGY, INC. (PBYI) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: $54.37M2012: $128.91M2013: $83.99M2014: $117.05M2015: $206.01M2016: $209.82M2017: $53.30M2018: $34.31M2019: $17.46M2020: -$5.95M2021: -$2.45M2022: $21.61M2023: $53.44M2024: $92.12M2025: $130.34M$130.34M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$130.34M+41.5%2024$92.12M+72.4%2023$53.44M+147.3%2022$21.61M+983.4%2021-$2.45M+58.9%2020-$5.95M-134.1%2019$17.46M-49.1%2018$34.31M-35.6%2017$53.30M-74.6%2016$209.82M+1.9%2015$206.01M+76.0%2014$117.05M+39.4%2013$83.99M-34.8%2012$128.91M+137.1%2011$54.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share